As cell therapies move closer to widespread clinical application, cryopreservation is playing an increasingly important role in maintaining product quality across manufacturing, storage, and distribution. Beyond preserving cells, affective cryopreservation strategies can help support scalability, cosnistency, and commercial success.
Discover the latest insights and best practices in RegMedNet's newest In Focus feature on cryopreservation in cell therapy development.
Infographic
Cryopreservation can influence everything from post-thaw performance to regulatory readiness. Our infographic highlights key considerations for optimizing cryopreservation workflows and preserving cell function.
From the infographic, you’ll learn:
- Why viability alone is not enough to assess post-thaw cell quality
- Key cryopreservation considerations for different cell types
- How optimized media can reduce freeze-thaw damage
- The importance of GMP-ready and animal component-free solutions
Expert interview
We spoke with Laura Aschmis, Scientific Support Specialist, GMP Business Unit, and Iris Bischoff-Kont, Senior Product Manager, about the evolving role of cryopreservation in cell therapy development.
What you'll learn from the interview:
- Why cryopreservation is becoming a strategic part of cell therapy workflows
- Which quality attributes should be assessed beyond viability
- Challenges associated with stem cells and primary cells
- Emerging innovations in cryopreservation technologies
- How early process decisions can support future clinical translation
This interview was made in collaboration with RegMedNet.
Unlock better cryopreservation outcomes Explore practical insights, expert perspectives, and emerging approaches to help optimize cryopreservation strategies throughout cell therapy development.